End to end CDMO services for the importation, encapsulation and distribution of T3S and Placebo for the LIONNS-D2 Trial
Cardiff University needs a contract development and manufacturing organisation (CDMO) to import, encapsulate, store, label and distribute pharmaceutical products for a clinical trial. The work includes handling T3S (triiodothyronine sulphate) and placebo tablets from a Spanish manufacturer, over-encapsulating commercially sourced L-thyroxine capsules, and distributing finished packs to Royal Glamorgan Hospital.
- Closed30 January 2026
- Value£421k
- BuyerCardiff University
- WhereRoyal Glamorgan Hospital, Wales
- CategoryHealth & medical, Research & development
- RegionWales
You'll want to look if you operate as a CDMO with GMP accreditation, import capability, and experience handling investigational medicinal products for clinical trials
You'll need
- GMP compliance for import and quality person (QP) sign-off
- CDMO capability for encapsulation and clinical trial distribution
- storage and labelling facilities
Possible incumbent
Ardena Holding NV won the T3S manufacture contract on 2025-10-23, suggesting they may be the upstream supplier rather than the CDMO being sought here. Inferred from prior awards to this buyer, not confirmed.